Ohlmann
Andreas Ohlmann, Munchen DE
Patent application number | Description | Published |
---|---|---|
20110312872 | NORRIN IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN INCREASED TGF-BETA ACTIVITY - The present invention relates to Norrin or a functional fragment thereof in the treatment or prevention of diseases associated with an increased TGF-beta activity. In particular, the use of said Norrin or functional fragment thereof to treat fibrotic diseases/disorders or proliferative disorders, like cancers, is part of this invention. | 12-22-2011 |
Dominik Ohlmann, Namborn-Roschberg DE
Patent application number | Description | Published |
---|---|---|
20130225852 | Method To Prepare beta-Functionalized Aliphatic Esters - The invention pertains to a new route to prepare β-functionalized carboxylic acid esters in a one-pot reaction, by reacting an olefinic acid ester in the presence of a catalyst system, comprising a Rh(I)-complex, together with an aryl boron or a diamine as nucleophilic compounds, and under oxygen-free conditions and elevated temperatures. | 08-29-2013 |
20130340327 | Process For Preparing Unsaturated Compounds - Aspects of the present invention relate to processes for preparing compositions comprising unsaturated compounds, wherein (A) one or more unsaturated monocarboxylic acids having 10-24 carbon atoms or esters of these monocarboxylic acids and (B) one or more unsaturated dicarboxylic acids having 4 to 20 carbon atoms or esters thereof are subjected to a tandem isomerization/metathesis reaction in the presence of a palladium catalyst and of a ruthenium catalyst, with the proviso that the palladium catalysts used are compounds which contain at least one structural element Pd—P(R | 12-26-2013 |
20140046081 | Method for Producing Unsaturated Compounds - The invention relates to a method for producing compositions containing unsaturated compounds, wherein (A) one or more unsaturated monocarboxylic acids having 10 to 24 C-atoms or esters of said monocarboxylic acids and optionally (B) one or more compounds having at least one C═C double bond (wherein the compounds (B) are different from the compounds (A)) are subjected to a tandem isomerization/metathesis reaction sequence in the presence of a palladium catalyst and a ruthenium catalyst, providing that the palladium catalysts used are compounds that contain at least one structural element Pd—P(R | 02-13-2014 |
Hans-Armin Ohlmann, Ayr CA
Patent application number | Description | Published |
---|---|---|
20080196701 | Two-Stroke Internal Combustion Engine with Enhanced Scavenging - The engine has at least one cylinder ( | 08-21-2008 |
Joachim Ohlmann, Herzogenaurach DE
Patent application number | Description | Published |
---|---|---|
20100138003 | Automation Component for an Industrial Automation Arrangement and Method for Activating an Operational State - An automation component for an industrial automation arrangement, wherein the automation component is configured to control at least one system part, process or subprocess of the industrial automation arrangement. At least two different operating states are able to be alternately set for the at least one system part, process or subprocess, and the operational states which differ with respect to the respective power consumption of the system part, process or subprocess. The automation component is configured to receive requests for a changeover to one of the at least two different operational states, the automation component is configured to output acknowledgement messages in response to the requests, and the automation component is configured to output status messages relating to the activated operating state of the operational states. | 06-03-2010 |
20100168897 | Control Component and Method for an Energy Management Unit in an Industrial Automation Arrangement - A control component and method for an energy management unit (EM) in an industrial automation arrangement which is configured to control one of a process, a subprocess and a system part of the industrial automation arrangement. Here, the control component is configured to detect the energy consumption of at least one part of the industrial automation arrangement, and the control component is configured to relate the detected energy consumption to at least one stored specification. The control component is also configured to generate a request for at least one automation component as the result of the relating operation. The control component is configured to transmit a message containing the request to the automation component and to receive an acknowledgement message from this automation component, where the request is directed to changing an operational state of one of the process, subprocess and system part that is controlled by the automation component. | 07-01-2010 |
Marion Ohlmann, Munich DE
Patent application number | Description | Published |
---|---|---|
20100266630 | Recombinant MVA virus, and the use thereof - The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines. | 10-21-2010 |
20100291139 | RECOMBINANT MVA VIRUS AND THE USE THEREOF - The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines. | 11-18-2010 |
Theophile Ohlmann, Lyon Cedex 07 FR
Patent application number | Description | Published |
---|---|---|
20150376673 | Cell-Free Translation System - The present invention relates to a new cell-free translation system. In particular, the invention relates to a cell-free reaction system for translating in vitro a RNA into a protein, said reaction system comprising a ribosome-depleted red blood cell lysate and ribosomes isolated from eukaryotic cells, with the proviso that (1) when the ribosome-depleted red blood cell lysate is obtained from a nuclease untreated rabbit reticulocyte lysate, the eukaryotic cells from which ribosomes are isolated are not nuclease untreated rabbit reticulocytes, and (2) when the ribosome-depleted red blood cell lysate is obtained from a nuclease treated rabbit reticulocyte lysate, the eukaryotic cells from which ribosomes are isolated are not nuclease treated rabbit reticulocytes. The invention also pertains to a method for translating in vitro a ribonucleic acid template into an amino acid sequence of interest using the cell-free reaction system of the invention. The invention also relates to the use of (i) a ribosome-depleted red blood cell lysate, and (ii) ribosomes isolated from eukaryotic cells, with the proviso that (1) when the ribosome-depleted red blood cell lysate is obtained from a nuclease untreated rabbit reticulocyte lysate, the eukaryotic cells from which ribosomes are isolated are not nuclease untreated rabbit reticulocytes, and (2) when the ribosome-depleted red blood cell lysate is obtained from a nuclease treated rabbit reticulocyte lysate, the eukaryotic cells from which ribosomes are isolated are not nuclease treated rabbit reticulocytes, for producing a cell-free translation system. | 12-31-2015 |